Skip to main content
Premium Trial:

Request an Annual Quote

OGT Licenses Microarray IP to Invitrogen

NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed its oligonucleotide microarray patents to Invitrogen, OGT said today.
 
With the license, Invitrogen can offer DNA related microarray services to customers worldwide from its US operations.
 
The license will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.
 
OGT licensed its patents to four Japanese companies in August: Yamatake, NGK Insulators, Bio Matrix Research, and Filgen.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.